[Federal Register Volume 81, Number 215 (Monday, November 7, 2016)]
[Notices]
[Pages 78201-78207]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26782]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


United States v. Fayez Sarofim; Proposed Final Judgment and 
Competitive Impact Statement

    Notice is hereby given pursuant to the Antitrust Procedures and 
Penalties Act, 15 U.S.C. 16(b)-(h), that a proposed Final Judgment, 
Stipulation, and Competitive Impact Statement have been filed with the 
United States District Court for the District of Columbia in United 
States of America v. Fayez Sarofim, Civil Action No. 1:16-cv-02156. On 
October 27, 2016, the United States filed a Complaint alleging that 
Fayez Sarofim violated the premerger notification and waiting period 
requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 
1976, 15 U.S.C. 18a, with respect to his acquisitions of voting 
securities of Kinder Morgan, Inc. and Kemper Corporation. The proposed 
Final Judgment, filed at the same time as the Complaint, requires Fayez 
Sarofim to pay a civil penalty of $720,000.
    Copies of the Complaint, proposed Final Judgment, and Competitive 
Impact Statement are available for inspection on the Antitrust 
Division's Web site at http://www.justice.gov/atr and at the Office of 
the Clerk of the United States District Court for the District of 
Columbia. Copies of these materials may be obtained from the Antitrust 
Division upon request and payment of the copying fee set by Department 
of Justice regulations.
    Public comment is invited within 60 days of the date of this 
notice. Such comments, including the name of the submitter, and 
responses thereto, will be posted on the Antitrust Division's Web site, 
filed with the Court, and, under certain circumstances, published in 
the Federal Register. Comments should be directed to Daniel P. Ducore, 
Special Attorney, United States, c/o Federal Trade Commission, 600 
Pennsylvania Avenue NW., CC-8416, Washington, DC 20580 (telephone: 202-
326-2526; email: [email protected]).

Patricia A. Brink,
Director of Civil Enforcement.

In the United States District Court for the District of Columbia

    UNITED STATES OF AMERICA, c/o Department of Justice, Washington, 
D.C. 20530, Plaintiff, v. Fayez Sarofim, Two Houston Center, Suite 
2907, Houston, TX 77010, Defendant.

Case No.: 1:16-cv-02156
Judge: Rudolph Contreras
Filed: 10/27/2016

[[Page 78202]]

Complaint for Civil Penalties for Failure To Comply With the Premerger 
Reporting and Waiting Requirements of the Hart-Scott Rodino act

    The United States of America, Plaintiff, by its attorneys, acting 
under the direction of the Attorney General of the United States and at 
the request of the Federal Trade Commission, brings this civil 
antitrust action to obtain monetary relief in the form of civil 
penalties against Defendant Fayez Sarofim (``Sarofim''). Plaintiff 
alleges as follows:

Nature of the Action

    1. Sarofim violated the notice and waiting period requirements of 
the Hart-Scott-Rodino Antitrust Improvements Act of 1976, 15 U.S.C. 18a 
(``HSR Act'' or ``Act''), with respect to the acquisition of voting 
securities of Kinder Morgan, Inc. (``KMI'') and Kemper Corporation 
(``Kemper'').

Jurisdiction and Venue

    2. This Court has jurisdiction over the subject matter of this 
action pursuant to Section 7A(g) of the Clayton Act, 15 U.S.C. 18a(g), 
and pursuant to 28 U.S.C. 1331, 1337(a), 1345, and 1355 and over the 
Defendant by virtue of Defendant's consent, in the Stipulation relating 
hereto, to the maintenance of this action and entry of the Final 
Judgment in this District.
    3. Venue is properly based in this District by virtue of 
Defendant's consent, in the Stipulation relating hereto, to the 
maintenance of this action and entry of the Final Judgment in this 
District.

The Defendant

    4. Defendant Sarofim is a natural person with his principal office 
and place of business at Two Houston Center, Suite 2907, Houston, TX 
77010. Sarofim is engaged in commerce, or in activities affecting 
commerce, within the meaning of Section 1 of the Clayton Act, 15 U.S.C. 
12, and Section 7A(a)(1) of the Clayton Act, 15 U.S.C. 18a(a)(1). At 
all times relevant to this complaint, Sarofim had sales or assets in 
excess of $151.7 million.

Other Entities

    5. KMI is a corporation organized under the laws of Delaware with 
its principal place of business at 1001 Louisiana Street, Houston, TX 
77002. KMI is engaged in commerce, or in activities affecting commerce, 
within the meaning of Section 1 of the Clayton Act, 15 U.S.C. 12, and 
Section 7A(a)(1) of the Clayton Act, 15 U.S.C. 18a(a)(1). At all times 
relevant to this complaint, KMI had sales or assets in excess of $15.3 
million.
    6. Kemper is a corporation organized under the laws of Delaware 
with its principal place of business at One Kemper Drive, Long Grove, 
IL 60049. Kemper is engaged in commerce, or in activities affecting 
commerce, within the meaning of Section 1 of the Clayton Act, 15 U.S.C. 
12, and Section 7A(a)(1) of the Clayton Act, 15 U.S.C. 18a(a)(1). At 
all times relevant to this complaint, Kemper had sales or assets in 
excess of $15.3 million.

The Hart-Scott-Rodino Act and Rules

    7. The HSR Act requires certain acquiring persons and certain 
persons whose voting securities or assets are acquired to file 
notifications with the federal antitrust agencies and to observe a 
waiting period before consummating certain acquisitions of voting 
securities or assets. 15 U.S.C. 18a(a) and (b). These notification and 
waiting period requirements apply to acquisitions that meet the HSR 
Act's thresholds. Prior to February 1, 2001, the HSR Act's reporting 
and waiting period requirements applied to most transactions where the 
acquiring person would hold more than $15 million of the acquired 
person's voting securities and/or assets, except for certain exempted 
transactions. As of February 1, 2001, the size of transaction threshold 
was increased to $50 million. In addition, there is a separate filing 
requirement for transactions in which the acquirer will hold voting 
securities in excess of $100 million, and for transactions in which the 
acquirer will hold voting securities in excess of $500 million. Since 
2004, the size of person and size of transaction thresholds have been 
adjusted annually.
    8. The HSR Act's notification and waiting period requirements are 
intended to give the federal antitrust agencies prior notice of, and 
information about, proposed transactions. The waiting period is also 
intended to provide the federal antitrust agencies with an opportunity 
to investigate a proposed transaction and to determine whether to seek 
an injunction to prevent the consummation of a transaction that may 
violate the antitrust laws.
    9. Section (c)(9) of the HSR Act, 15 U.S.C. 18a(c)(9), exempts from 
the requirements of the HSR Act acquisitions of voting securities 
solely for the purpose of investment if, as a result of the 
acquisition, the securities acquired or held do not exceed ten percent 
of the outstanding voting securities of the issuer.
    10. Pursuant to Section (d)(2) of the HSR Act, 15 U.S.C. 18a(d)(2), 
rules were promulgated to carry out the purposes of the HSR Act. 16 CFR 
801-03 (``HSR Rules''). The HSR Rules, among other things, define terms 
contained in the HSR Act.
    11. Pursuant to section 801.13(a)(1) of the HSR Rules, 16 CFR 
801.13(a)(1), ``all voting securities of [an] issuer which will be held 
by the acquiring person after the consummation of an acquisition''--
including any held before the acquisition--are deemed held ``as a 
result of'' the acquisition at issue.
    12. Pursuant to sections 801.13(a)(2) and 801.10(c)(1) of the HSR 
Rules, 16 CFR 801.13(a)(2) and Sec.  801.10(c)(1), the value of voting 
securities already held is the market price, defined to be the lowest 
closing price within 45 days prior to the subsequent acquisition.
    13. Section 801.1(i)(1) of the HSR Rules, 16 CFR 801.1(i)(1), 
defines the term ``solely for the purpose of investment'' as follows:

    Voting securities are held or acquired ``solely for the purpose 
of investment'' if the person holding or acquiring such voting 
securities has no intention of participating in the formulation, 
determination, or direction of the basic business decisions of the 
issuer.

    14. Section 7A(g)(1) of the Clayton Act, 15 U.S.C. 18a(g)(1), 
provides that any person, or any officer, director, or partner thereof, 
who fails to comply with any provision of the HSR Act is liable to the 
United States for a civil penalty for each day during which such person 
is in violation. From November 20, 1996, through February 9, 2009, the 
maximum amount of civil penalty was $11,000 per day, pursuant to the 
Debt Collection Improvement Act of 1996, Public Law 104-134, 31001(s) 
(amending the Federal Civil Penalties Inflation Adjustment Act of 1990, 
28 U.S.C. 2461 note), and Federal Trade Commission Rule 1.98, 16 CFR 
1.98, 61 FR 54548 (Oct. 21, 1996). As of February 10, 2009, the maximum 
amount of civil penalty was increased to $16,000 per day, pursuant to 
the Debt Collection Improvement Act of 1996, Public Law 104-134, 
31001(s) (amending the Federal Civil Penalties Inflation Adjustment Act 
of 1990, 28 U.S.C. 2461 note), and Federal Trade Commission Rule 1.98, 
16 CFR 1.98, 74 FR 857 (Jan. 9, 2009). Pursuant to the Federal Civil 
Penalties Inflation Adjustment Act Improvements Act of 2015, Public Law 
114-74, 701 (further amending the Federal Civil Penalties Inflation 
Adjustment Act of 1990), and Federal Trade Commission Rule 1.98, 16 CFR 
1.98, 81 FR 42,476 (June 30, 2016), the maximum amount of civil penalty 
was increased to $40,000 per day.

[[Page 78203]]

Defendant's Violations of the HSR Act

Failure To File HSR Act Notifications in Connection With Acquisitions 
of KMI Voting Securities

    15. Sarofim was an early investor in KMI and, by August 1999, held 
KMI shares valued at approximately $50 million. Sarofim's acquisitions 
of KMI securities up until that time were exempt under the HSR Act 
because they were covered by the Act's exemption of acquisitions made 
solely for the purpose of investment.
    16. In October 1999, Sarofim became a member of the KMI board, a 
position that necessarily caused him to participate in the formulation, 
determination, or direction of the basic business decisions of KMI. As 
a result, Sarofim could no longer rely on the exemption for 
acquisitions made solely for the purpose of investment with regard to 
KMI. Sarofim continued to be a member of KMI's board through 2014.
    17. On January 23, 2001, Sarofim acquired 237,500 shares of KMI on 
the open market. At the time of the acquisition, Sarofim already held 
voting securities of KMl. The value of the voting securities held by 
Sarofim after the acquisition was in excess of the then applicable $15 
million size of transaction threshold.
    18. Although he was required to do so, Sarofim did not file under 
the HSR Act prior to acquiring KMI voting securities on January 23, 
2001, improperly relying on the exemption for acquisitions made solely 
for the purpose of investment.
    19. Sarofim continued to acquire KMI voting securities, through 
open market purchases and otherwise.
    20. On July 16, 2006, Sarofim acquired an additional 1,600 shares 
of KMI as compensation for serving on KMI's board. As a result of this 
acquisition, Sarofim held KMI voting securities valued in excess of 
$113.4 million, the adjusted $100 million threshold in effect at the 
time.
    21. Although he was required to do so, Sarofim did not file under 
the HSR Act prior to acquiring KMI voting securities on July 16, 2006.
    22. On May 30, 2007, Sarofim's KMI voting securities were converted 
into shares of Knight Holdco, LLC, later named Kinder Morgan Holdco, 
LLC. This transaction was exempt from the HSR premerger notification 
and waiting period requirements. After this transaction, Sarofim no 
longer held any voting securities of KMI.
    23. On November 11, 2011, Sarofim's shares of Kinder Morgan Holdco, 
LLC were converted into voting securities of KMI. This transaction was 
exempt from the HSR premerger notification and waiting period 
requirements.
    24. On October 25, 2012, Sarofim acquired 300,000 shares of KMI on 
the open market. As a result of this acquisition, Sarofim held KMI 
voting securities valued in excess of $682.1 million, the adjusted $500 
million threshold in effect at the time.
    25. Although he was required to do so, Sarofim did not file under 
the HSR Act prior to acquiring KMI voting securities on October 25, 
2012.
    26. Sarofim continued to acquire KMI voting securities, on the open 
market and otherwise, through at least June 4, 2014.
    27. On November 21, 2014, Sarofim made three corrective filings 
under the HSR Act, for the three notification thresholds he crossed 
through the 2001, 2006, and 2012 acquisitions. The waiting period on 
the corrective filings expired on December 22, 2014.
    28. Sarofim was in continuous violation of the HSR Act from January 
23, 2001, when he acquired the KMI voting securities valued in excess 
of the HSR Act's then applicable $15 million size-of-transaction 
threshold, through May 30, 2007, when he no longer held voting 
securities of KMI.
    29. Sarofim was again in continuous violation of the HSR Act from 
October 25, 2012, when he acquired the KMI voting securities valued in 
excess of the then $682.1 million threshold then in effect, through 
December 22, 2014, when the waiting period expired.

Failure To File HSR Act Notification in Connection With Acquisition of 
Kemper Voting Securities

    30. Sarofim was an investor in Teledyne, Inc., an industrial 
conglomerate that owned Unitrin Inc., the predecessor company to 
Kemper. In 1990, Unitrin was spun off from Teledyne, and investors in 
Teledyne, including Sarofim, received pro-rata shares of Unitrin as a 
result. Sarofim joined the Unitrin board shortly after the spinoff.
    31. On May 10, 2007, Sarofim acquired 10,000 shares of Unitrin 
Inc., the predecessor to Kemper, on the open market. At the time of the 
acquisition, Sarofim already held voting securities of Unitrin. The 
value of the voting securities held by Sarofim after the acquisition 
was in excess of the then applicable size-of-the-transaction threshold 
of $59.8 million.
    32. At the time of the May 10, 2007 acquisition, Sarofim was a 
member of Unitrin's board of directors, and Sarofim continued to be a 
member of Kemper's board through 2014.
    33. Because he was on the Unitrin board, Sarofim could not rely on 
the exemption for acquisitions solely for the purpose of investment.
    34. Although he was required to do so, Sarofim did not file under 
the HSR Act prior to acquiring Unitrin voting securities on May 10, 
2007.
    35. Sarofim continued to acquire Unitrin/Kemper voting securities, 
through open market purchases and otherwise, through at least September 
10, 2008.
    36. On or about august 19, 2011, Unitrin changed its name to 
Kemper.
    37. On November 21, 2014, Sarofim made a corrective filing under 
the HSR Act for the acquisition of Unitrin/Kemper voting securities. 
The waiting period on the corrective filings expired on December 22, 
2014.
    38. Sarofim was in continuous violation of the HSR Act from May 10, 
2007, when he acquired the Unitrin voting securities valued in excess 
of the HSR Act's then applicable $59.8 million size-of-transaction 
threshold, through December 22, 2014, when the waiting period expired.

Requested Relief

    Wherefore, Plaintiff requests:
    a. That the Court adjudge and decree that Defendant Sarofim's 
acquisitions of KMI voting securities on January 23, 2001, July 16, 
2006, and October 25, 2012, were violations of the HSR Act, 15 U.S.C. 
18a; and that Defendant Sarofim was in violation of the HSR Act each 
day from January 23, 2001, through May 30, 2007, and from October 25, 
2012, through December 22, 2014;
    b. That the Court adjudge and decree that Defendant Sarofim's 
acquisition of Kemper voting securities on May 10, 2007, was a 
violation of the HSR Act, 15 U.S.C. 18a; and that Defendant Sarofim was 
in violation of the HSR Act each day from May 10, 2007, through 
December 22, 2014;
    c. That the Court order Defendant Sarofim to pay to the United 
States an appropriate civil penalty as provided by the HSR Act. 15 
U.S.C. 18a(g)(1), the Debt Collection Improvement Act of 1996, Public 
Law 104-134, 31001(s) (amending the Federal Civil Penalties Inflation 
Adjustment Act of 1990, 28 U.S.C. 2461 note), and Federal Trade 
Commission Rule 1.98, 16 CFR 1.98, 74 FR 857 (Jan. 9, 2009), and the 
Federal Civil Penalties Inflation Adjustment Act Improvements Act of 
2015, Public Law 114-74, 701 (further amending the Federal Civil 
Penalties Inflation Adjustment Act of 1990), and Federal Trade 
Commission Rule 1.98, 16 CFR 1.98, 81 FR 42,476 (June 30, 2016)

[[Page 78204]]

    d. That the Court order such other and further relief as the Court 
may deem just and proper; and
    e. That the Court award the Plaintiff its costs of this suit.

Dated: October 27, 2016

For the Plaintiff United States of America:

/s/--------------------------------------------------------------------

Renata B. Hesse,
D.C. Bar No. 466107,

Acting Assistant Attorney General Special Attorney, Department of 
Justice, Antitrust Division, Washington, DC 20530.

/s/--------------------------------------------------------------------

Daniel P. Ducore,
D.C. Bar No. 933721,

Special Attorney.

/s/--------------------------------------------------------------------

Roberta S. Baruch,
D.C. Bar No. 269266,

Special Attorney.

/s/--------------------------------------------------------------------

Kenneth A. Libby,

Special Attorney.

/s/--------------------------------------------------------------------

Jennifer Lee,

Special Attorney, Federal Trade Commission, Washington, DC 20580, 
(202) 326-2694.

United States District Court for the District of Columbia

United States of America, Plaintiff, v. Fayez Sarofim, Defendant.

Case No.: 1:16-cv-02156
Judge: Rudolph Contreras
Filed: 10/27/2016

Competitive Impact Statement

    The United States, pursuant to the Antitrust Procedures and 
Penalties Act (``APPA''), 15 U.S.C. 16(b)-(h), files this Competitive 
Impact Statement to set forth the information necessary to enable the 
Court and the public to evaluate the proposed Final Judgment that would 
terminate this civil antitrust proceeding.

I. Nature and Purpose of This Proceeding

    On October 27, 2017, the United States filed a Complaint against 
Defendant Fayez Sarofim (``Sarofim''), related to Sarofim's 
acquisitions of voting securities of Kinder Morgan, Inc. (``KMI'') and 
Kemper Corporation (``Kemper'') between January 2001 and December 2014. 
The Complaint alleges that Sarofim violated Section 7A of the Clayton 
Act, 15 U.S.C. 18a, commonly known as the Hart-Scott-Rodino Antitrust 
Improvements Act of 1976 (the ``HSR Act''). The HSR Act provides that 
``no person shall acquire, directly or indirectly, any voting 
securities of any person'' exceeding certain thresholds until that 
person has filed pre-acquisition notification and report forms with the 
Department of Justice and the Federal Trade Commission (collectively, 
the ``federal antitrust agencies'' or ``agencies'') and the post-filing 
waiting period has expired. 15 U.S.C. 18a(a). A key purpose of the 
notification and waiting period is to protect consumers and competition 
from potentially anticompetitive transactions by providing the agencies 
an opportunity to conduct an antitrust review of proposed transactions 
before they are consummated.
    The Complaint alleges that Sarofim acquired voting securities of 
KMI and Kemper in excess of then-applicable statutory thresholds 
without making the required pre-acquisition HSR filings with the 
agencies and without observing the waiting period, and that Sarofim and 
each of KMI and Kemper met the applicable statutory size of person 
thresholds.
    At the same time the Complaint was filed in the present action, the 
United States also filed a Stipulation and proposed Final Judgment that 
eliminates the need for a trial in this case. The proposed Final 
Judgment is designed to deter Sarofim's HSR Act violations. Under the 
proposed Final Judgment, Sarofim must pay a civil penalty to the United 
States in the amount of $720,000.
    The United States and the Defendant have stipulated that the 
proposed Final Judgment may be entered after compliance with the APPA, 
unless the United States first withdraws its consent. Entry of the 
proposed Final Judgment would terminate this case, except that the 
Court would retain jurisdiction to construe, modify, or enforce the 
provisions of the proposed Final Judgment and punish violations 
thereof.

II. Description of the Events Giving Rise to the Alleged Violations of 
the Antitrust Laws

A. Sarofim's 2001, 2006, and 2012 Acquisitions of KMI Voting Securities

    Sarofim is an investor. Sarofim is the second-largest shareholder 
in KMI. At all times relevant to the Complaint, Sarofim had sales or 
assets in excess of $151.7 million.
    Headquartered in Houston, Texas, KMI is the largest energy 
infrastructure company in North America. At all times relevant to the 
Complaint, KMI had sales or assets in excess of $15.3 million.
    Sarofim was an early investor in KMI and, by August 1999, held KMI 
shares valued at approximately $50 million. Sarofim's acquisitions of 
KMI securities up until that time were exempt under the HSR Act because 
they were covered by the Act's investment-only exemption, which exempts 
``acquisitions, solely for the purpose of investment, of voting 
securities, if, as a result of such acquisition, the securities 
acquired or held do not exceed 10 per centum of the outstanding voting 
securities of the issuer.'' 15 U.S.C. 18a(c)(9). The HSR Rules provide 
that securities are held ``solely for the purpose of investment'' if 
the person holding or acquiring the securities has ``no intention of 
participating in the formulation, determination, or direction of the 
basic business decisions of the issuer.'' 16 CFR 801.1(i)(1).
    In October 1999, Sarofim became a member of the KMI board, a 
position that necessarily caused him to participate in the formulation, 
determination, or direction of the basic business decisions of KMI. On 
January 23, 2001, Sarofim, while still a KMI board member, acquired 
237,000 shares of KMI on the open market. As a result of this 
acquisition, Sarofim held KMI voting securities valued at over the $15 
million HSR threshold that was then in place. Sarofim improperly relied 
on the investment-only exemption and did not make an HSR filing in 
connection with the 2001 acquisition.
    Sarofim again failed to make HSR filings when he crossed the two 
subsequent filing thresholds related to his holdings in KMI. On July 
16, 2006, Sarofim acquired 1,600 shares of KMI as compensation for 
serving on the KMI board. As a result of this acquisition, Sarofim held 
KMI voting securities valued over the $113.4 million filing threshold. 
On May 30, 2007, Sarofim's KMI voting securities were converted into 
shares of Knight Holdco, LLC, later named Kinder Morgan Holdco, LLC. 
This transaction was exempt from the HSR premerger notification and 
waiting period requirements. After this transaction, Sarofim no longer 
held any voting securities of KMI. On November 11, 2011, Sarofim's 
shares of Kinder Morgan Holdco, LLC were converted into voting 
securities of KMI. This transaction was exempt from the HSR premerger 
notification and waiting period requirements. Later, on October 25, 
2012, Sarofim purchased 300,000 shares of KMI on the open market. As a 
result of that acquisition, Sarofim held KMI voting securities valued 
in excess of the $682.1 million filing threshold.
    Sarofim made corrective HSR Act filings on November 21, 2014, after 
learning that he had improperly relied on the investment-only exemption 
and was obligated to file. The waiting period expired on December 22, 
2014.

[[Page 78205]]

B. Sarofim's Acquisitions of Kemper Voting Securities

    Kemper Corporation is an insurance holding company, with 
subsidiaries that provide automobile, homeowners, life, health, and 
other insurance products to individuals and businesses. At all times 
relevant to the Complaint, Kemper had sales or assets in excess of 
$15.3 million.
    Sarofim was an investor in Teledyne, Inc., an industrial 
conglomerate that owned Unitrin Inc., the predecessor company to 
Kemper. In 1990, Unitrin was spun off from Teledyne, and investors in 
Teledyne, including Sarofim, received pro-rata shares of Unitrin as a 
result. Sarofim joined the Unitrin board shortly after the spinoff.
    On May 10, 2007, Sarofim, while still a Unitrin board member, 
acquired 10,000 shares of Unitrin on the open market. As a result of 
the acquisition, Sarofim held Unitrin voting securities valued over 
$59.8 million, the threshold that was then in place. Sarofim again 
improperly relied on the investment-only exemption and did not make an 
HSR Act filing. Sarofim could not rely on the investment-only exemption 
because of his status as a Unitrin board member. Through at least 
September 10, 2008, Sarofim made numerous purchases of Unitrin voting 
securities on the open market without making HSR Act filings. On or 
about August 19, 2011, Unitrin changed its name to Kemper.
    Sarofim made a corrective HSR Act filing on November 21, 2014, 
after learning that he had improperly relied on the investment-only 
exemption and was obligated to file. The waiting period expired on 
December 22, 2014.

III. Explanation of the Proposed Final Judgment

    The proposed Final Judgment imposes a $720,000 civil penalty 
designed to deter the Defendant and others from violating the HSR Act. 
The United States adjusted the penalty downward from the maximum 
permitted under the HSR Act because the violations were inadvertent, 
the Defendant promptly self-reported the violations after discovery, 
and the Defendant is willing to resolve the matter by consent decree 
and avoid prolonged investigation and litigation. The relief will have 
a beneficial effect on competition because the agencies will be 
properly notified of future acquisitions, in accordance with the law. 
At the same time, the penalty will not have any adverse effect on 
competition.

IV. Remedies Available to Potential Private Litigants

    There is no private antitrust action for HSR Act violations; 
therefore, entry of the proposed Final Judgment will neither impair nor 
assist the bringing of any private antitrust action.

V. Procedures Available for Modification of the Proposed Final Judgment

    The United States and the Defendant have stipulated that the 
proposed Final Judgment may be entered by this Court after compliance 
with the provisions of the APPA, provided that the United States has 
not withdrawn its consent. The APPA conditions entry of the decree upon 
this Court's determination that the proposed Final Judgment is in the 
public interest.
    The APPA provides a period of at least sixty (60) days preceding 
the effective date of the proposed Final Judgment within which any 
person may submit to the United States written comments regarding the 
proposed Final Judgment. Any person who wishes to comment should do so 
within sixty (60) days of the date of publication of this Competitive 
Impact Statement in the Federal Register, or the last date of 
publication in a newspaper of the summary of this Competitive Impact 
Statement, whichever is later. All comments received during this period 
will be considered by the United States, which remains free to withdraw 
its consent to the proposed Final Judgment at any time prior to entry. 
The comments and the response of the United States will be filed with 
this Court. In addition, comments will be posted on the U.S. Department 
of Justice, Antitrust Division's internet Web site and, under certain 
circumstances, published in the Federal Register. Written comments 
should be submitted to: Daniel P. Ducore, Special Attorney, United 
States, c/o Federal Trade Commission, 600 Pennsylvania Avenue NW., CC-
8416, Washington, DC 20580, Email: [email protected].
    The proposed Final Judgment provides that this Court retains 
jurisdiction over this action, and the parties may apply to this Court 
for any order necessary or appropriate for the modification, 
interpretation, or enforcement of the Final Judgment.

VI. Alternatives to the Proposed Final Judgment

    As an alternative to the proposed Final Judgment, the United States 
considered pursuing a full trial on the merits against the Defendant. 
The United States is satisfied, however, that the proposed relief is an 
appropriate remedy in this matter. Given the facts of this case, 
including the Defendant's self-reporting of the violation and 
willingness to promptly settle this matter, the United States is 
satisfied that the proposed civil penalty is sufficient to address the 
violation alleged in the Complaint and to deter violations by similarly 
situated entities in the future, without the time, expense, and 
uncertainty of a full trial on the merits.

VII. Standard of Review Under the APPA for the Proposed Final Judgment

    The APPA requires proposed consent judgments in antitrust cases 
brought by the United States be subject to a sixty (60) day comment 
period, after which the court shall determine whether entry of the 
proposed Final Judgment is ``in the public interest.'' 15 U.S.C. 
16(e)(1). In making that determination, the court, in accordance with 
the statute as amended in 2004, is required to consider:

    (A) the competitive impact of such judgment, including 
termination of alleged violations, provisions for enforcement and 
modification, duration of relief sought, anticipated effects of 
alternative remedies actually considered, whether its terms are 
ambiguous, and any other competitive considerations bearing upon the 
adequacy of such judgment that the court deems necessary to a 
determination of whether the consent judgment is in the public 
interest; and
    (B) the impact of entry of such judgment upon competition in the 
relevant market or markets, upon the public generally and 
individuals alleging specific injury from the violations set forth 
in the complaint including consideration of the public benefit, if 
any, to be derived from a determination of the issues at trial.

Id. Sec.  16(e)(1)(A) & (B). In considering these statutory factors, 
the court's inquiry is necessarily a limited one, as the government is 
entitled to ``broad discretion to settle with the defendant within the 
reaches of the public interest.'' United States v. Microsoft Corp., 56 
F.3d 1448, 1461 (D.C. Cir. 1995); see generally United States v. SBC 
Commc'ns, Inc., 489 F. Supp. 2d 1 (D.D.C. 2007) (assessing public 
interest standard under the Tunney Act); United States v. U.S. Airways 
Group, Inc., 38 F. Supp. 3d 69, 75 (D.D.C. 2014) (noting that the 
court's ``inquiry is limited'' because the government has ``broad 
discretion'' to determine the adequacy of the relief secured through a 
settlement); United States v. InBev N.V./S.A., No. 08-1965 (JR), 2009-2 
Trade Cas. (CCH) ] 76,736, 2009 U.S. Dist. LEXIS 84787, at *3 (D.D.C. 
Aug. 11, 2009) (noting that the court's review of a consent judgment is 
limited and only

[[Page 78206]]

inquires ``into whether the government's determination that the 
proposed remedies will cure the antitrust violations alleged in the 
complaint was reasonable, and whether the mechanism to enforce the 
final judgment are clear and manageable.'').\1\
---------------------------------------------------------------------------

    \1\ The 2004 amendments substituted ``shall'' for ``may'' in 
directing relevant factors for court to consider and amended the 
list of factors to focus on competitive considerations and to 
address potentially ambiguous judgment terms. Compare 15 U.S.C. 
16(e) (2004), with 15 U.S.C. 16(e)(1) (2006); see also SBC Commc'ns, 
489 F. Supp. 2d at 11 (concluding that the 2004 amendments 
``effected minimal changes'' to Tunney Act review).
---------------------------------------------------------------------------

    As the United States Court of Appeals for the District of Columbia 
Circuit has held, a court conducting an inquiry under the APPA may 
consider, among other things, the relationship between the remedy 
secured and the specific allegations set forth in the government's 
complaint, whether the decree is sufficiently clear, whether 
enforcement mechanisms are sufficient, and whether the decree may 
positively harm third parties. See Microsoft, 56 F.3d at 1458-62. With 
respect to the adequacy of the relief secured by the decree, a court 
may not ``engage in an unrestricted evaluation of what relief would 
best serve the public.'' United States v. BNS, Inc., 858 F.2d 456, 462 
(9th Cir. 1988) (quoting United States v. Bechtel Corp., 648 F.2d 660, 
666 (9th Cir. 1981)); see also Microsoft, 56 F.3d at 1460-62; United 
States v. Alcoa, Inc., 152 F.
    Supp. 2d 37, 40 (D.D.C. 2001); InBev, 2009 U.S. Dist. LEXIS 84787, 
at *3. Courts have held that:

[t]he balancing of competing social and political interests affected 
by a proposed antitrust consent decree must be left, in the first 
instance, to the discretion of the Attorney General. The court's 
role in protecting the public interest is one of insuring that the 
government has not breached its duty to the public in consenting to 
the decree. The court is required to determine not whether a 
particular decree is the one that will best serve society, but 
whether the settlement is ``within the reaches of the public 
interest.'' More elaborate requirements might undermine the 
effectiveness of antitrust enforcement by consent decree.

    Bechtel, 648 F.2d at 666 (emphasis added) (citations omitted).\2\ 
In determining whether a proposed settlement is in the public interest, 
a district court ``must accord deference to the government's 
predictions about the efficacy of its remedies, and may not require 
that the remedies perfectly match the alleged violations.'' SBC 
Commc'ns, 489 F. Supp. 2d at 17; see also U.S. Airways, 38 F. Supp. 3d 
at 75 (noting that a court should not reject the proposed remedies 
because it believes others are preferable); Microsoft, 56 F.3d at 1461 
(noting the need for courts to be ``deferential to the government's 
predictions as to the effect of the proposed remedies''); United States 
v. Archer-Daniels-Midland Co., 272 F. Supp. 2d 1, 6 (D.D.C. 2003) 
(noting that the court should grant due respect to the government's 
prediction as to the effect of proposed remedies, its perception of the 
market structure, and its views of the nature of the case).
---------------------------------------------------------------------------

    \2\ Cf. BNS, 858 F.2d at 464 (holding that the court's 
``ultimate authority under the [APPA] is limited to approving or 
disapproving the consent decree''); United States v. Gillette Co., 
406 F. Supp. 713, 716 (D. Mass. 1975) (noting that, in this way, the 
court is constrained to ``look at the overall picture not 
hypercritically, nor with a microscope, but with an artist's 
reducing glass''). See generally Microsoft, 56 F.3d at 1461 
(discussing whether ``the remedies [obtained in the decree are] so 
inconsonant with the allegations charged as to fall outside of the 
`reaches of the public interest' '').
---------------------------------------------------------------------------

    Courts have greater flexibility in approving proposed consent 
decrees than in crafting their own decrees following a finding of 
liability in a litigated matter. ``[A] proposed decree must be approved 
even if it falls short of the remedy the court would impose on its own, 
as long as it falls within the range of acceptability or is `within the 
reaches of public interest.' '' United States v. Am. Tel. & Tel. Co., 
552 F. Supp. 131, 151 (D.D.C. 1982) (citations omitted) (quoting United 
States v. Gillette Co., 406 F. Supp. 713, 716 (D. Mass. 1975)), aff'd 
sub nom., Maryland v. United States, 460 U.S. 1001 (1983); see also 
U.S. Airways, 38 F. Supp. 3d at 76 (noting that room must be made for 
the government to grant concessions in the negotiation process for 
settlements (citing Microsoft, 56 F.3d at 1461)); United States v. 
Alcan Aluminum Ltd., 605 F. Supp. 619, 622 (W.D. Ky. 1985) (approving 
the consent decree even though the court would have imposed a greater 
remedy). To meet this standard, the United States ``need only provide a 
factual basis for concluding that the settlements are reasonably 
adequate remedies for the alleged harms.'' SBC Commc'ns, 489 F. Supp. 
2d at 17.
    Moreover, the court's role under the APPA is limited to reviewing 
the remedy in relationship to the violations that the United States has 
alleged in its Complaint, and does not authorize the court to 
``construct [its] own hypothetical case and then evaluate the decree 
against that case.'' Microsoft, 56 F.3d at 1459; see also U.S. Airways, 
38 F. Supp. 3d at 75 (noting that the court must simply determine 
whether there is a factual foundation for the government's decisions 
such that its conclusions regarding the proposed settlements are 
reasonable); InBev, 2009 U.S. Dist. LEXIS 84787, at *20 (concluding 
that ``the `public interest' is not to be measured by comparing the 
violations alleged in the complaint against those the court believes 
could have, or even should have, been alleged''). Because the ``court's 
authority to review the decree depends entirely on the government's 
exercising its prosecutorial discretion by bringing a case in the first 
place,'' it follows that ``the court is only authorized to review the 
decree itself,'' and not to ``effectively redraft the complaint'' to 
inquire into other matters that the United States did not pursue. 
Microsoft, 56 F.3d at 1459-60. As this Court confirmed in SBC 
Communications, courts ``cannot look beyond the complaint in making the 
public interest determination unless the complaint is drafted so 
narrowly as to make a mockery of judicial power.'' 489 F. Supp. 2d at 
15.
    In its 2004 amendments, Congress made clear its intent to preserve 
the practical benefits of utilizing consent decrees in antitrust 
enforcement, adding the unambiguous instruction that ``[n]othing in 
this section shall be construed to require the court to conduct an 
evidentiary hearing or to require the court to permit anyone to 
intervene.'' 15 U.S.C. 16(e)(2); see also U.S. Airways, 38 F. Supp. 3d 
at 76 (indicating that a court is not required to hold an evidentiary 
hearing or to permit intervenors as part of its review under the Tunney 
Act). This language codified what Congress intended when it enacted the 
Tunney Act in 1974, as the author of this legislation, Senator Tunney, 
explained: ``The court is nowhere compelled to go to trial or to engage 
in extended proceedings which might have the effect of vitiating the 
benefits of prompt and less costly settlement through the consent 
decree process.'' 119 Cong. Rec. 24,598 (1973) (statement of Sen. 
Tunney). Rather, the procedure for the public interest determination is 
left to the discretion of the court, with the recognition that the 
court's ``scope of review remains sharply proscribed by precedent and 
the nature of Tunney Act proceedings.'' SBC Commc'ns, 489 F. Supp. 2d 
at 11.\3\

[[Page 78207]]

A court can make its public interest determination based on the 
competitive impact statement and response to public comments alone. 
U.S. Airways, 38 F. Supp. 3d at 76.
---------------------------------------------------------------------------

    \3\ See also United States v. Enova Corp., 107 F. Supp. 2d 10, 
17 (D.D.C. 2000) (noting that the ``Tunney Act expressly allows the 
court to make its public interest determination on the basis of the 
competitive impact statement and response to comments alone''); 
United States v. Mid-Am. Dairymen, Inc., No. 73-CV-681-W-1, 1977-1 
Trade Cas. (CCH) ] 61,508, at 71,980, *22 (W.D. Mo. 1977) (``Absent 
a showing of corrupt failure of the government to discharge its 
duty, the Court, in making its public interest finding, should . . . 
carefully consider the explanations of the government in the 
competitive impact statement and its responses to comments in order 
to determine whether those explanations are reasonable under the 
circumstances.''); S. Rep. No. 93-298, at 6 (1973) (``Where the 
public interest can be meaningfully evaluated simply on the basis of 
briefs and oral arguments, that is the approach that should be 
utilized.'').
---------------------------------------------------------------------------

VIII. Determinative Documents

    There are no determinative materials or documents within the 
meaning of the APPA that were considered by the United States in 
formulating the proposed Final Judgment.

Date: October 27, 2016

Respectfully Submitted,

/s/ Kenneth A. Libby

Kenneth A. Libby,

Special Attorney, U.S. Department of Justice, Antitrust Division, c/
o Federal Trade Commission, 600 Pennsylvania Avenue NW., Washington, 
DC 20580, Phone: (202) 326-2694, Email: [email protected].

United States District Court for the District of Columbia

United States of America, Plaintiff, v. Fayez Sarofim, Defendant.

Case No.: 1:16-cv-02156
Judge: Rudolph Contreras
Filed: 10/27/2016

Final Judgment

    Plaintiff, the United States of America, having commenced this 
action by filing its Complaint herein for violation of Section 7A of 
the Clayton Act, 15 U.S.C. 18a, commonly known as the Hart-Scott-Rodino 
Antitrust Improvements Act of 1976, and Plaintiff and Defendant Fayez 
Sarofim, by their respective attorneys, having consented to the entry 
of this Final Judgment without trial or adjudication of any issue of 
fact or law herein, and without this Final Judgment constituting any 
evidence against or an admission by the Defendant with respect to any 
such issue:
    Now therefore, before the taking of any testimony and without trial 
or adjudication of any issue of fact or law herein, and upon the 
consent of the parties hereto, it is hereby
    Ordered, adjudged, and decreed:

I.

    The Court has jurisdiction of the subject matter of this action and 
of the Plaintiff and the Defendant. The Complaint states a claim upon 
which relief can be granted against the Defendant under Section 7A of 
the Clayton Act, 15 U.S.C. 18a.

II.

    Judgment is hereby entered in this matter in favor of Plaintiff 
United States of America and against Defendant, and, pursuant to 
Section 7A(g)(1) of the Clayton Act, 15 U.S.C. 18a(g)(1), the Debt 
Collection Improvement Act of 1996, Public Law 104-134 Sec.  31001(s) 
(amending the Federal Civil Penalties Inflation Adjustment Act of 1990, 
28 U.S.C. 2461), and Federal Trade Commission Rule 1.98, 16 CFR 1.98, 
61 FR 54549 (Oct. 21, 1996), and 74 FR 857 (Jan. 9, 2009), and the 
Federal Civil Penalties Inflation Adjustment Act Improvements Act of 
2015, Public Law 114-74 Sec.  701 (further amending the Federal Civil 
Penalties Inflation Adjustment Act of 1990), and Federal Trade 
Commission Rule 1.98, 16 CFR 1.98, 81 FR 42,476 (June 30, 2016), 
Defendant Fayez Sarofim is hereby ordered to pay a civil penalty in the 
amount of seven hundred twenty thousand dollars ($720,000). Payment of 
the civil penalty ordered hereby shall be made by wire transfer of 
funds or cashier's check. If the payment is made by wire transfer, 
Defendant shall contact Janie Ingalls of the Antitrust Division's 
Antitrust Documents Group at (202) 514-2481 for instructions before 
making the transfer. If the payment is made by cashier's check, the 
check shall be made payable to the United States Department of Justice 
and delivered to: Janie Ingalls, United States Department of Justice, 
Antitrust Division, Antitrust Documents Group, 450 5th Street NW., 
Suite 1024, Washington, DC 20530.
    Defendant shall pay the full amount of the civil penalty within 
thirty (30) days of entry of this Final Judgment. In the event of a 
default or delay in payment, interest at the rate of eighteen (18) 
percent per annum shall accrue thereon from the date of the default or 
delay to the date of payment.

III.

    Each party shall bear its own costs of this action.

IV.

    The entry of this Final Judgment is in the public interest. The 
parties have complied with the requirements of the Antitrust Procedures 
and Penalties Act, 15 U.S.C. 16, including making copies available to 
the public of this Final Judgment, the Competitive Impact Statement, 
and any comments thereon and the United States' responses to comments. 
Based upon the record before the Court, which includes the Competitive 
Impact Statement and any comments and response to comments filed with 
the Court, entry of this Final Judgment is in the public interest.

Dated:-----------------------------------------------------------------

-----------------------------------------------------------------------

United States District Judge

[FR Doc. 2016-26782 Filed 11-4-16; 8:45 am]
BILLING CODE